Valuation check: BAYRY's profit margin is -3.84%, below the Healthcare sector average of 15.29%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Bayer AG (BAYRY) currently reports a profit margin of -3.84% as of June 2026. That compares with -7.4% in the prior-year period — up 48.1% year over year. That is below the Healthcare sector average of 15.29%. Use the charts on this page to explore Bayer AG's profit margin history and peer comparisons.
Bayer AG's profit margin increased from -7.4% to -3.84% — a 48.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Bayer AG's profit margin of -3.84% is lower than the Healthcare sector average of 15.29%. That is roughly 125.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Bayer AG's current -3.84% should be judged against Healthcare norms (sector average: 15.29%) and against BAYRY's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -3.84%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.29%. From there, open related valuation or income-statement pages for Bayer AG, and consider following BAYRY for alerts when major investors trade the stock.